Limpet M Tablet (Extended Release) 2 mg+500 mg is a combination of two medicines (a sulfonylurea and a biguanide) used for the treatment of type 2 diabetes mellitus (a condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood). This medicine works by lowering blood sugar levels and increasing insulin sensitivity in the body. It also helps reduce the risk of developing complications associated with diabetes.
Limpet M Tablet (Extended Release) 2 mg+500 mg is used to treat type 2 diabetes mellitus in adults. It is a non-insulin based medication that helps lower blood sugar levels and improve insulin sensitivity. It may also be used in combination with other medicines to treat type 2 diabetes mellitus.
| Brand Name | Limpet M |
|---|---|
| Type | Tablet (Extended Release) |
| Weight | 2 mg+500 mg |
| Generic | Glimepiride + Metformin |
| Manufacturer | Drug International Ltd. |
| Available in | English বাংলা |
Glimepiride belongs to a class of medications called sulfonylureas. It stimulates the release of insulin from the pancreas, which helps lower blood sugar levels.Metformin belongs to a class of medications called biguanides. It reduces the production of glucose in the liver and increases insulin sensitivity in the body, which helps lower blood sugar levels. When used together, Limpet M Tablet (Extended Release) 2 mg+500 mg helps lower blood sugar levels more effectively.
The effects of Limpet M Tablet (Extended Release) 2 mg+500 mg can vary depending on the individual and the dosage used. Generally, Limpet M Tablet (Extended Release) 2 mg+500 mg should take effect within 2 to 4 weeks of starting the medication. However, it may take up to 12 weeks to experience the full benefits of the medication.
Glimepiride is rapidly absorbed from the gastrointestinal tract. Metformin is moderately absorbed from the gastrointestinal tract. Both medications are highly bioavailable, meaning that they are quickly and effectively absorbed into the bloodstream.
Glimepiride is metabolized in the liver and excreted in the urine. Metformin is excreted in the urine unchanged and also undergoes some metabolic breakdown in the liver.
The recommended starting dose is one tablet of Limpet M Tablet (Extended Release) 2 mg+500 mg 1 mg/500 mg taken once daily with the evening meal unless otherwise directed by the physician. The dose may be increased by a maximum of two tablets per day as needed to control blood sugar levels. The maximum dosage should not exceed 8 tablets per day.
Limpet M Tablet (Extended Release) 2 mg+500 mg should be taken once daily with the evening meal. It should be swallowed whole with water, and not crushed, split, or chewed.
Common side effects of Limpet M Tablet (Extended Release) 2 mg+500 mg include headache, nausea, vomiting, abdominal pain, and diarrhea. More serious side effects may include low blood sugar (hypoglycemia), lactic acidosis, and allergic reactions. If any of these side effects occur, contact a doctor immediately.
The toxic dose of Limpet M Tablet (Extended Release) 2 mg+500 mg is not known. It should not be taken in excess of the recommended dose. If an overdose is suspected, seek medical attention immediately.
Patients should inform their doctor all medicines they are taking, including nonprescription medications, vitamins, and herbal supplements. Patients should avoid alcohol while taking Limpet M Tablet (Extended Release) 2 mg+500 mg as it may worsen the side effects. It is important to tell the doctor or pharmacist if you are pregnant, trying to become pregnant, or breastfeeding as Limpet M Tablet (Extended Release) 2 mg+500 mg may not be suitable in these cases.
Limpet M Tablet (Extended Release) 2 mg+500 mg may interact with other medications. Tell the doctor or pharmacist all the medications you are taking to prevent interactions between medications. In addition, some medications may reduce or increase the effect of Limpet M Tablet (Extended Release) 2 mg+500 mg, so it is important to tell the doctor or pharmacist if you are taking any other medications.
Limpet M Tablet (Extended Release) 2 mg+500 mg should be used with caution in patients with kidney or liver disease, as well as in those with diabetic ketoacidosis. It should also be used with caution in patients with heart disease, as it may worsen symptoms.
Limpet M Tablet (Extended Release) 2 mg+500 mg may interact with certain drugs, including ACE inhibitors, beta-blockers, lithium, and diuretics. It may also interact with other medications used to treat diabetes, such as insulin and metformin. It is important to tell the doctor or pharmacist about all medications taken to prevent interactions.
It is recommended to take Limpet M Tablet (Extended Release) 2 mg+500 mg with meals to reduce the possibility of adverse reactions. Avoid drinking alcohol while taking this medication as it may worsen the side effects.
Limpet M Tablet (Extended Release) 2 mg+500 mg is pregnancy category C and should not be used during pregnancy unless the benefits outweigh the risks. Patients should inform the doctor if they are pregnant or plan to become pregnant.
It is unknown if Limpet M Tablet (Extended Release) 2 mg+500 mg passes into breast milk. Therefore, it is not recommended for use while breastfeeding. Patients should inform the doctor if they are breastfeeding or plan to breastfeed.
Symptoms of an overdose may include nausea, vomiting, confusion, difficulty breathing, and drowsiness. If an overdose is suspected, seek medical attention immediately.
Limpet M Tablet (Extended Release) 2 mg+500 mg is contraindicated in patients with known hypersensitivity to either medication
Limpet M Tablet (Extended Release) 2 mg+500 mg should be taken as directed by the doctor. Do not take in larger or smaller amounts than recommended and do not take for longer than directed. Swallow whole with water and do not crush, split, or chew the tablets. Do not stop taking this medicine abruptly without consulting with your doctor.
Store Limpet M Tablet (Extended Release) 2 mg+500 mg at room temperature, away from light, heat, and moisture. Keep this and all medications out of the reach of children.
The volume of distribution of Limpet M Tablet (Extended Release) 2 mg+500 mg is not known.
The half-life of Glimepiride is approximately 5 to 8 hours, while the half-life of Metformin is approximately 6 to 8 hours.
The clearance of Glimepiride and Metformin from the body is not known.
See in details version Limpet M Tablet (Extended Release) 2 mg+500 mg also Limpet M Tablet (Extended Release) 2 mg+500 mg in bangla